Aqsusten 25 (Progesterone Vials) 25mg/1ml

AQSUSTEN 25 is a progesterone injection in vial form, delivering 25mg per 1ml for hormone therapy support. Used to address hormonal imbalances and related conditions, this medication is prescribed under medical supervision. Ideal for patients requiring progesterone supplementation.

Strength

25mg/1ml

Manufacturer / TM Owner

Sun Pharmaceutical Ind Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Progesterone is a hormone used to treat conditions caused by low hormone levels in women, such as irregular menstrual cycles or menopausal symptoms. It may also support fertility treatments by preparing the uterine lining for embryo implantation. Often prescribed for women experiencing hormonal imbalances or undergoing assisted reproductive therapies.

Side Effects

Progesterone helps regulate the menstrual cycle and supports early pregnancy by maintaining the uterine lining. Patients may notice improved cycle regularity and reduced symptoms associated with hormonal fluctuations. Some users report a sense of balance in reproductive health after consistent use.

Precautions & Warnings

Store vials at room temperature, away from moisture and heat. Keep out of reach of children and pets. Always use as directed by a healthcare professional. Discard any unused medication after the prescribed treatment period. Avoid exposure to extreme temperatures during storage or transport.

Avoid Interactions

Progesterone may interact with medications that affect liver enzymes, such as certain antifungals or anticonvulsants. Combining it with corticosteroids or anticoagulants may alter effectiveness. Alcohol and tobacco use should be discussed with a doctor, as they may influence hormone therapy outcomes.

Frequently Asked Questions

AQSUSTEN 25 is a progesterone injection used to address hormonal imbalances in women, such as irregular periods or menopausal symptoms.

It is administered via injection as prescribed by a healthcare provider, typically into muscle or under the skin.

Some users may experience mild side effects like dizziness, breast tenderness, or changes in menstrual flow.

Progesterone is often prescribed during pregnancy to support early stages, but use should be monitored by a doctor.

AQSUSTEN 25 may be available through licensed pharmacies with a valid prescription.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.